Aug 1 (Reuters) - Revolution Medicines Inc RVMD.O :
* REVOLUTION MEDICINES, INC. TO ACQUIRE EQRX, INC. IN
ALL-STOCK
TRANSACTION TO GAIN MORE THAN $1 BILLION IN ADDITIONAL CAPITAL
* REVOLUTION MEDICINES INC - WILL ACQUIRE EQRX IN AN
ALL-STOCK
TRANSACTION
* REVOLUTION MEDICINES: SOME EQRX STOCKHOLDERS, REPRESENTING
MORE
THAN 40% OF VOTING SHARES OF EQRX, ENTERED AGREEMENTS TO VOTE
SHARES IN FAVOR OF DEAL
* REVOLUTION MEDICINES - AT CLOSE OF TRANSACTION, ONE EQRX
DIRECTOR WILL BE DESIGNATED BY REVOLUTION MEDICINES TO SERVE ON
ITS BOARD OF DIRECTORS
* REVOLUTION MEDICINES - UPON COMPLETION OF TRANSACTION,
EQRX
SHARES WILL CEASE TRADING ON NASDAQ GLOBAL MARKET
* REVOLUTION MEDICINES-TO CONCENTRATE POST-MERGER FINANCIAL,
HUMAN
CAPITAL ON 3 PRIORITY RAS-FOCUSED ASSETS & PIPELINE OF
MUTANT-SELECTIVE RAS(ON) INHIBITORS
Source text for Eikon: ID:nGNX3fSpDn
Further company coverage: RVMD.O
((Reuters.Briefs@thomsonreuters.com;))